Your browser doesn't support javascript.
[Progress in research of specific antibody dynamic characteristics in patients with COVID-19].
Zhao, H T; Peng, Z B; Yang, X K; Li, Z L; Ren, M R; Qin, Y; Sun, X J; Yu, J X; An, Z J; Mao, N Y; Xu, W W; Li, Z J.
  • Zhao HT; Division of Infectious Disease, Key Laboratory of Infectious Disease Surveillance and Early-warning, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Peng ZB; Branch of Respiratory Disease, Division of Infectious Disease, Key Laboratory of Infectious Disease Surveillance and Ear-warning, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Yang XK; Division of Infectious Disease, Key Laboratory of Infectious Disease Surveillance and Early-warning, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Li ZL; Division of Infectious Disease, Key Laboratory of Infectious Disease Surveillance and Early-warning, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Ren MR; Division of Infectious Disease, Key Laboratory of Infectious Disease Surveillance and Early-warning, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Qin Y; Branch of Respiratory Disease, Division of Infectious Disease, Key Laboratory of Infectious Disease Surveillance and Ear-warning, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Sun XJ; National Immunization Programme, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
  • Yu JX; National Institute for Communicable Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • An ZJ; National Immunization Programme, Chinese Center for Disease Control and Prevention, Beijing 100050, China.
  • Mao NY; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Xu WW; National Institute for Viral Disease Control and Prevention, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
  • Li ZJ; Division of Infectious Disease, Key Laboratory of Infectious Disease Surveillance and Early-warning, Chinese Center for Disease Control and Prevention, Beijing 102206, China.
Zhonghua Liu Xing Bing Xue Za Zhi ; 42(1): 39-43, 2021 Jan 10.
Article in Chinese | MEDLINE | ID: covidwho-769441
ABSTRACT
COVID-19 is an emerging infectious disease caused by SARS-CoV-2. After the infection of the virus, the host immune system is stimulated to produce multifarious specific antibodies to decrease or eliminate effects of the pathogen. Study of the specific antibodies dynamic characteristics in patients with COVID-19 is very important for the understanding and diagnosis of the disease, research and development of vaccine, and planning of prevention and control strategy. This paper reviews and summarizes the domestic and oversea research on dynamic characteristics of specific antibodies of COVID-19 patients, including the antibody producing, duration and level, and its possible influencing factors in order to improve the understanding of the immunological characteristics of COVID-19.
Subject(s)
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Antibodies, Viral Topics: Vaccines Limits: Humans Language: Chinese Journal: Zhonghua Liu Xing Bing Xue Za Zhi Year: 2021 Document Type: Article Affiliation country: Cma.j.cn112338-20200809-01047

Similar

MEDLINE
LILACS
LIS
Fulltext
Print
XML
PubMed Links
Search on Google

Full text: Available Collection: International databases Database: MEDLINE Main subject: COVID-19 / Antibodies, Viral Topics: Vaccines Limits: Humans Language: Chinese Journal: Zhonghua Liu Xing Bing Xue Za Zhi Year: 2021 Document Type: Article Affiliation country: Cma.j.cn112338-20200809-01047